In addition, immunotherapy-resistant melanoma patients also express higher levels of phosphorylated S111 LSD1, similarly modulating stem-like EMT signatures and altering LSD1’s transcription regulation network in cancer-specific cells (42, 44). The gene discussed is KDM1A; the disease is cancer.